Literature DB >> 23223063

Hiding under the skin: Interleukin-17-producing γδ T cells go under the skin?

Burkhard Becher1, Stanislav Pantelyushin.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23223063     DOI： 10.1038/nm.3016

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

Review 1.  Psoriasis.

Authors:  Gayathri K Perera; Paola Di Meglio; Frank O Nestle
Journal:  Annu Rev Pathol       Date:  2011-11-04       Impact factor: 23.472

2.  Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

Authors:  Michel Gilliet; Curdin Conrad; Michael Geiges; Antonio Cozzio; Wolfgang Thürlimann; Günter Burg; Frank O Nestle; Reinhard Dummer
Journal:  Arch Dermatol       Date:  2004-12

3.  Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.

Authors:  Christopher E M Griffiths; Bruce E Strober; Peter van de Kerkhof; Vincent Ho; Roseanne Fidelus-Gort; Newman Yeilding; Cynthia Guzzo; Yichuan Xia; Bei Zhou; Shu Li; Lisa T Dooley; Neil H Goldstein; Alan Menter
Journal:  N Engl J Med       Date:  2010-01-14       Impact factor: 91.245

4.  A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.

Authors:  Robert Bissonnette; Kim Papp; Catherine Maari; Yihong Yao; Gabriel Robbie; Wendy I White; Chenxiong Le; Barbara White
Journal:  J Am Acad Dermatol       Date:  2010-03       Impact factor: 11.527

5.  Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis.

Authors:  A B Gottlieb; C Leonardi; F Kerdel; S Mehlis; M Olds; D A Williams
Journal:  Br J Dermatol       Date:  2011-08-04       Impact factor: 9.302

6.  Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.

Authors:  Craig Leonardi; Robert Matheson; Claus Zachariae; Gregory Cameron; Linda Li; Emily Edson-Heredia; Daniel Braun; Subhashis Banerjee
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

7.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.

Authors:  Kim A Papp; Craig Leonardi; Alan Menter; Jean-Paul Ortonne; James G Krueger; Gregory Kricorian; Girish Aras; Juan Li; Chris B Russell; Elizabeth H Z Thompson; Scott Baumgartner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

Review 8.  APC-derived cytokines and T cell polarization in autoimmune inflammation.

Authors:  Ilona Gutcher; Burkhard Becher
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis.

Authors:  Sabina A Antoniu
Journal:  Expert Opin Investig Drugs       Date:  2012-07-27       Impact factor: 6.206

10.  Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha.

Authors:  Onur Boyman; Hans Peter Hefti; Curdin Conrad; Brian J Nickoloff; Mark Suter; Frank O Nestle
Journal:  J Exp Med       Date:  2004-02-23       Impact factor: 14.307
View more
  30 in total

1.  Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells.

Authors:  Xuan Sun; Yihua Cai; Chris Fleming; Zan Tong; Zhenglong Wang; Chuanlin Ding; Minye Qu; Huang-Ge Zhang; Jian Suo; Jun Yan
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

2.  Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.

Authors:  Melissa G Works; Fangfang Yin; Catherine C Yin; Ying Yiu; Kenneth Shew; Thanh-Thuy Tran; Nahoko Dunlap; Jennifer Lam; Tim Mitchell; John Reader; Paul L Stein; Annalisa D'Andrea
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

3.  Dermal Vγ4+T cells enhance the IMQ-induced psoriasis-like skin inflammatidon in re-challenged mice.

Authors:  Rong Zhu; Xiaowei Cai; Chunli Zhou; Yashu Li; Xiaorong Zhang; Yiqian Li; Lei Ran; Ke Huang; Weifeng He; Rupeng Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

4.  IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.

Authors:  Andrew L Croxford; Susanne Karbach; Florian C Kurschus; Simone Wörtge; Alexei Nikolaev; Nir Yogev; Sabrina Klebow; Rebecca Schüler; Sonja Reissig; Carolin Piotrowski; Elke Brylla; Ingo Bechmann; Jürgen Scheller; Stefan Rose-John; F Thomas Wunderlich; Thomas Münzel; Esther von Stebut; Ari Waisman
Journal:  J Invest Dermatol       Date:  2013-09-25       Impact factor: 8.551

5.  T Cell-Independent Mechanisms Associated with Neutrophil Extracellular Trap Formation and Selective Autophagy in IL-17A-Mediated Epidermal Hyperplasia.

Authors:  Erika Suzuki; Emanual Maverakis; Ritu Sarin; Laura Bouchareychas; Vijay K Kuchroo; Frank O Nestle; Iannis E Adamopoulos
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

6.  Serum amyloid A induces interleukin-1β secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome.

Authors:  N Yu; S Liu; X Yi; S Zhang; Y Ding
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

7.  MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.

Authors:  Ruifang Wu; Jinrong Zeng; Jin Yuan; Xinjie Deng; Yi Huang; Lina Chen; Peng Zhang; Huan Feng; Zixin Liu; Zijun Wang; Xiaofei Gao; Haijing Wu; Honglin Wang; Yuwen Su; Ming Zhao; Qianjin Lu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

8.  GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.

Authors:  Xichun Xia; Guangchao Cao; Guodong Sun; Leqing Zhu; Yixia Tian; Yueqi Song; Chengbin Guo; Xiao Wang; Jingxiang Zhong; Wei Zhou; Peng Li; Hua Zhang; Jianlei Hao; Zhizhong Li; Liehua Deng; Zhinan Yin; Yunfei Gao
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.

Authors:  G Guggino; F Ciccia; D Di Liberto; M Lo Pizzo; P Ruscitti; P Cipriani; A Ferrante; G Sireci; F Dieli; J J Fourniè; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

Review 10.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.